--- canonical_url: https://www.stockexpertai.com/earnings/mlm last_updated: 2026-05-05T22:46:52.720Z --- # Martin Marietta Materials, Inc. (MLM) Q1 FY2027 Earnings Preview > This content was automatically generated with FMP live data + Q1 FY2026 earnings call transcript. Generated: 2026-05-05T22:46:52.344Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $606.10 (▲ 0.47%) | fmp:quote | | Market Cap | $36.6B | fmp:profile | | 52w range | $530.86 – $710.97 | fmp:quote | | Earnings | Thu 6 Aug | fmp:earnings-history | | EPS estimate | $5.14 (-5% YoY) | fmp:earnings-estimate | | Revenue estimate | $1.9B | fmp:earnings-estimate | | Beat streak | 1/4 | fmp:earnings-history | | Rating | A- (overall 4/5) | fmp:ratings | | Analyst median target | $696 (+14.8% upside) | fmp:price-target-consensus | | MoonshotScore | 30/100 | derived | | Council | 2/6 bullish | derived | | Munger verdict | Fairly Valued | derived | ## Martin Marietta Materials, Inc. — Q1 FY2027 Expectations Q1 consensus: revenue $1.9B^{[FMP est]}, EPS $5.14^{[FMP est]}. 1 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** A- · **Stance:** HOLD · **Council:** 2/6 · **Moonshot:** 30 = MoonshotScore 30^{[9-pillar formula]} + Council 2/6^{[6-lens rule]}. Form 4: 0 transactions^{[FMP Form 4]}. ## Watchlist (6 metrics) ### 1. Specialties Business Growth Martin Marietta's Specialties business achieved record revenues of $143 million, up 63% year-over-year. > "Our Specialties business also achieved new all-time quarterly records with revenues of $143 million, up 63% year-over-year and gross profit of $45 million, an increase of 17%." > — C. Nye, Investor Focus · Q1 FY2026 ### 2. Full Year Ebitda Guidance Martin Marietta reaffirmed its full year 2026 adjusted EBITDA guidance of $2.43 billion. > "With April's continued strong product demand, the impact of April 1 price increases and ongoing optimization efforts, we're reaffirming our full year 2026 adjusted EBITDA from continuing operations guidance of $2.43 billion at the midpoint." > — C. Nye, Expectation / Guide · Q1 FY2026 ### 3. Record Revenue Martin Marietta reported record first quarter revenues of $1.4 billion, a 17% increase. > "2026 is off to a strong start with revenues increasing an impressive 17% to $1.4 billion, a new first quarter record." > — C. Nye, Investor Focus · Q1 FY2026 ### 4. Quikrete Asset Exchange Martin Marietta's Quikrete Asset Exchange shifted the portfolio away from more cyclical cement and concrete assets, providing $450 million of cash. > "Importantly, this transaction accelerated our aggregate sludge strategy by shifting the portfolio away from more cyclical cement and concrete assets, enhancing the quality and durability of our earnings profile, while providing $450 million of cash to redeploy into aggregate acquisitions accordingly." > — C. Nye, Investor Focus · Q1 FY2026 ### 5. Organic Aggregate Shipments Martin Marietta's organic aggregate shipments grew by 7.2%, exceeding guidance. > "Organic aggregate shipments growth of 7.2% meaningfully exceeded our guidance, benefiting from an early start to the construction season in the Midwest and Colorado as well as continued strength in infrastructure and heavy nonresidential demand across our geographic footprint." > — C. Nye, Investor Focus · Q1 FY2026 ### 6. New Frontier Materials Acquisition Martin Marietta entered into a definitive agreement to acquire New Frontier Materials, which produces over 8 million tons of aggregates annually. > "And consistent with the company's SOAR 2030 strategic plan, on April 19, we entered into a definitive agreement to acquire New Frontier materials, a complementary bolt-on to our central division that produces over 8 million tons of aggregates annually." > — C. Nye, Investor Focus · Q1 FY2026 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 0.0 | weak | Q1 vs Q2: growth negative (-24.8%, contraction) | | Gross Margin | 2.0 | weak | Q1: low margin (22.8%, capital-intensive or commodity) | | Operating Leverage | 1.0 | weak | op margin average (11.9%) | | Cash Runway | 5.0 | medium | FCF under pressure ($0.0B FCF vs $0.2B CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) | | Price Momentum | 4.0 | medium | RSI 46.5 balanced, 50d below | | News Sentiment | 6.0 | medium | majority buy (64%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +14.8% | | Ken Griffin | bear | flow · 50d MA below | | Jim Simons | neutral | quant · RSI 47 | | Klarman | neutral | value · target upside +14.8% | | Buffett | bull | quality · ROE score 5/5 | | Munger | neutral | valuation · target upside +14.8% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Fairly Valued - **Financial Health:** Strong - **Margin of Safety:** Moderate - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 46.5 — dengeli — yön sinyali zayıf - **50d MA:** $612 — hisse %1.0 altında — kısa vadeli direnç - **200d MA:** $622 — hisse %2.5 altında — uzun vadeli baskı - **Volume (10d):** -9% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q2 FY25 | $5.43 | $5.31 | BEAT | +1.8% | | Q3 FY25 | $5.97 | $6.72 | MISS | -2.3% | | Q4 FY25 | $3.85 | $4.78 | MISS | -0.2% | | Q1 FY26 | $1.93 | $1.78 | +8.4% EPS | -0.7% | Q1 (April 30, 2026): EPS $1.93 vs $1.78 est^[FMP], +8.4% beat. D+1 movement: -0.7%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q1 EPS > $5.14 + CapEx discipline** Threshold: EPS > $5.14^{[FMP est]}. Target: Break above median target $696^{[FMP target]}; high target $785^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $5.14 + CapEx < $186.0M** Threshold: EPS ≈ $5.14^{[FMP est]}, Q1 CapEx < $186.0M^[FMP]. Target: Consolidation in the band between current $606^[FMP] and median $696^[FMP]. ### Scenario C · Miss **EPS < $4.99 or CapEx ≥ $186.0M** Threshold: EPS < $4.99^{[FMP est×0.97]}. Target: Current $606 below SMA200 $622^[FMP], if rejection continues, $529^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q1: EPS $1.93 vs $1.78 beat^[FMP], stock -0.7% D+1^[FMP]. ### Backlog concentration No RPO/backlog concentration disclosed in Q1 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q1 FY26 ### CapEx shock Q1 CapEx $186.0M^{[FMP cashflow]}. Q1 op margin 11.9%^{[FMP op margin]} — this level in Q1 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $696 (+14.8% upside vs current $606) - **High / Low:** $785 / $608 - **Buy / Hold / Sell:** 14 / 7 / 1 - **Analyst count:** 12 (last quarter), 46 all-time ## Additional Transcript Insights ### 1. record_revenue **Claim:** Martin Marietta reported record first quarter revenues of $1.4 billion, a 17% increase. **Evidence (transcript):** "2026 is off to a strong start with revenues increasing an impressive 17% to $1.4 billion, a new first quarter record." **Numbers:** %17, $1.4 billion ### 2. organic_aggregate_shipments **Claim:** Martin Marietta's organic aggregate shipments grew by 7.2%, exceeding guidance. **Evidence (transcript):** "Organic aggregate shipments growth of 7.2% meaningfully exceeded our guidance, benefiting from an early start to the construction season in the Midwest and Colorado as well as continued strength in infrastructure and heavy nonresidential demand across our geographic footprint." **Numbers:** 7.2% ### 3. adjusted_ebitda_improvement **Claim:** Martin Marietta reported a 14% improvement in both adjusted EBITDA and adjusted earnings per diluted share. **Evidence (transcript):** "Notably, the quarter's results reflect a 14% improvement in both adjusted EBITDA from continuing operations as well as adjusted earnings per diluted share from continuing operations." **Numbers:** %14 ### 4. quikrete_asset_exchange **Claim:** Martin Marietta's Quikrete Asset Exchange shifted the portfolio away from more cyclical cement and concrete assets, providing $450 million of cash. **Evidence (transcript):** "Importantly, this transaction accelerated our aggregate sludge strategy by shifting the portfolio away from more cyclical cement and concrete assets, enhancing the quality and durability of our earnings profile, while providing $450 million of cash to redeploy into aggregate acquisitions accordingly." **Numbers:** $450 million ### 5. new_frontier_materials_acquisition **Claim:** Martin Marietta entered into a definitive agreement to acquire New Frontier Materials, which produces over 8 million tons of aggregates annually. **Evidence (transcript):** "And consistent with the company's SOAR 2030 strategic plan, on April 19, we entered into a definitive agreement to acquire New Frontier materials, a complementary bolt-on to our central division that produces over 8 million tons of aggregates annually." **Numbers:** 8 million ### 6. specialties_business_growth **Claim:** Martin Marietta's Specialties business achieved record revenues of $143 million, up 63% year-over-year. **Evidence (transcript):** "Our Specialties business also achieved new all-time quarterly records with revenues of $143 million, up 63% year-over-year and gross profit of $45 million, an increase of 17%." **Numbers:** $143 million, %63, $45 million, %17 ### 7. full_year_ebitda_guidance **Claim:** Martin Marietta reaffirmed its full year 2026 adjusted EBITDA guidance of $2.43 billion. **Evidence (transcript):** "With April's continued strong product demand, the impact of April 1 price increases and ongoing optimization efforts, we're reaffirming our full year 2026 adjusted EBITDA from continuing operations guidance of $2.43 billion at the midpoint." **Numbers:** 2026, $2.43 billion --- *Data source: FMP (live query, 2026-05-05), Q1 FY2026 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*